Neil Gregory Almstead, CHIEF TECHNICAL Operations OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 142,677 shares at $51.85 ($7.4M) on 2024-12-02, disclosed to the SEC on 2024-12-04.
Scheduled sale ($7.4M) by CHIEF TECHNICAL Operations OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.85 | 2,328 | $121K | 1.6% |
| 2 | $51.85 | 2,328 | $121K | 1.6% |
| 3 | $51.85 | 1,783 | $92K | 1.2% |
| 4 | $51.85 | 1,783 | $92K | 1.2% |
| 5 | $51.97 | 58,345 | $3.0M | 40.8% |
| 6 | $51.97 | 58,345 |
| $3.0M |
| 40.8% |
| 7 | $52.72 | 8,611 | $454K | 6.1% |
| 8 | $52.72 | 8,611 | $454K | 6.1% |
| 9 | $52.73 | 266 | $14K | 0.2% |
| 10 | $52.76 | 277 | $15K | 0.2% |
| Total | $52.06 avg | 142,677 | $7.4M | 100% |
| Filing → |
| PTCT | SELL | 2026-06-30 | $693K | — | Filing → |
| PTCT | SELL | 2026-06-26 | $2.3M | — | Filing → |
| PTCT | SELL | 2026-06-24 | $1.9M | — | Filing → |